Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Singapore Med J. 2012 Nov;53(11):e228-30.

Agomelatine reduces craving in benzodiazepine addicts: a follow-up examination of three patients.

Author information

  • 11Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg, Erlangen, Germany. helge.mueller@uk-erlangen.de

Abstract

The treatment of benzodiazepine withdrawal is difficult, and the search continues for substances that can reduce craving and the risk of relapse. Here, we report three cases of benzodiazepine addicts with histories of unsuccessful withdrawal attempts who experienced marked reductions in craving and improved relapse prognoses under add-on administration of agomelatine. These cases demonstrate a possible area of use for the antidepressant agomelatine in the treatment of benzodiazepine withdrawal and addiction. The extent to which this effect is due to the anti-craving effects of agomelatine, or its profile of receptor activation, should be further investigated in larger clinical and experimental studies.

PMID:
23192510
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Singapore Medical Association
    Loading ...
    Write to the Help Desk